Clinical and laboratory evaluation of National Health Service factor VIII concentrate (8Y) for the treatment of von Willebrand's disease
- 1 June 1990
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 75 (2) , 234-239
- https://doi.org/10.1111/j.1365-2141.1990.00234.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Binding of von Willebrand factor to glycoproteins Ib and IIb/IIIa complex: affinity is related to multimeric sizeBritish Journal of Haematology, 1989
- Comparison of the in vitro characteristics of von Willebrand factor in British and commercial factor VIII concentratesBritish Journal of Haematology, 1989
- Severely Heated Therapeutic Factor VIII Concentrate of High Specific ActivityVox Sanguinis, 1989
- Use of a High‐Purity Factor VIII Concentrate (Hemate P) in von Willebrand's Disease1Vox Sanguinis, 1989
- Characterization of von willebrand factor in factor VIII concentratesAmerican Journal of Hematology, 1989
- Biochemical and in vivo properties of commercial virus‐inactivated factor VIII concentratesEuropean Journal of Haematology, 1988
- Correction of the bleeding time in treated patients with severe von willebrand disease is not solely dependent on the normal multimeric structure of plasma von willebrand factorAmerican Journal of Hematology, 1987
- Absence of Hepatitis after Treatment with a Pasteurized Factor VIII Concentrate in Patients with Hemophilia and No Previous TransfusionsNew England Journal of Medicine, 1987
- MULTIMERIC ANALYSIS OF EIGHT LYOPHILIZED FACTOR VIII CONCENTRATESBritish Journal of Haematology, 1985
- FACTOR VIII RELATED ACTIVITIES IN CONCENTRATESScandinavian Journal of Haematology, 1984